Tag Archives: precision cancer care

AI-enhanced MRI analysis shows potential to accelerate metastatic prostate-cancer assessment and improve treatment decisions

Posted on 1, December 2025 by EuropaWire PR Editors

(IN BRIEF) Researchers at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust have developed AI software that automates the complex interpretation of whole-body diffusion-weighted MRI scans, which are increasingly used to evaluate advanced prostate cancer. The … Read the full press release →

Posted in Artificial Intelligence (AI), Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom

Tagged AI MRI prostate cancer, AI-driven MRI software could streamline metastatic tumour evaluation and support next-generation precision oncology, anatomical segmentation, Computer Methods and Programs in Biomedicine, Dr Antonio Candito, Dr Matthew Blackledge, lesion detection, metastatic prostate cancer, NIHR Invention for Innovation, personalised oncology, Physics in Medicine & Biology, precision cancer care, The Institute of Cancer Research London, The Royal Marsden NHS Foundation Trust, tumour burden quantification, WB-DWI, whole-body diffusion-weighted MRI